Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))

  • Ralph A. Defronzo
  • , Andrew Lewin
  • , Sanjay Patel
  • , Dacheng Liu
  • , Renee Kaste
  • , Hans J. Woerle
  • , Uli C. Broedl

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1173
Number of pages1
JournalDiabetes care
Volume38
Issue number6
DOIs
StatePublished - Jun 2015
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this